{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:51:14Z","timestamp":1791831074612,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007637","name":"Departamento Administrativo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["1115-545-31420"],"award-info":[{"award-number":["1115-545-31420"]}],"id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jcyt.2017.09.011","type":"journal-article","created":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T05:53:54Z","timestamp":1509688434000},"page":"45-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["PARKIN overexpression in human mesenchymal stromal cells from Wharton's jelly suppresses 6-hydroxydopamine\u2013induced apoptosis: Potential therapeutic strategy in Parkinson's disease"],"prefix":"10.1016","volume":"20","author":[{"given":"A.R.","family":"Bonilla-Porras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Arevalo-Arbelaez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.F.","family":"Alzate-Restrepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Velez-Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jimenez-Del-Rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"s1","key":"10.1016\/j.jcyt.2017.09.011_bib0010","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.3233\/JPD-179006","article-title":"The MPTP story","volume":"7","author":"Langston","year":"2017","journal-title":"J Parkinsons Dis"},{"issue":"6","key":"10.1016\/j.jcyt.2017.09.011_bib0015","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.mcp.2016.11.001","article-title":"Genetics of Parkinson's disease","volume":"30","author":"Lill","year":"2016","journal-title":"Mol Cell Probes"},{"issue":"4","key":"10.1016\/j.jcyt.2017.09.011_bib0020","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tibs.2015.02.003","article-title":"Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease","volume":"40","author":"Ryan","year":"2015","journal-title":"Trends Biochem Sci"},{"issue":"11","key":"10.1016\/j.jcyt.2017.09.011_bib0025","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1111\/febs.13249","article-title":"Parkin structure and function","volume":"282","author":"Seirafi","year":"2015","journal-title":"FEBS J"},{"issue":"16","key":"10.1016\/j.jcyt.2017.09.011_bib0030","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/hmg\/ddh180","article-title":"Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis","volume":"13","author":"Jiang","year":"2004","journal-title":"Hum Mol Genet"},{"issue":"11","key":"10.1016\/j.jcyt.2017.09.011_bib0035","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/aps.2015.54","article-title":"Parkin represses 6-hydroxydopamine-induced apoptosis via stabilizing scaffold protein p62 in PC12 cells","volume":"36","author":"Hou","year":"2015","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"10.1016\/j.jcyt.2017.09.011_bib0040","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s12640-015-9519-y","article-title":"Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update","volume":"27","author":"Segura-Aguilar","year":"2015","journal-title":"Neurotox Res"},{"issue":"4","key":"10.1016\/j.jcyt.2017.09.011_bib0045","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1212\/CON.0000000000000355","article-title":"Treating the motor symptoms of Parkinson disease","volume":"22","author":"Morgan","year":"2016","journal-title":"Continuum (N Y)"},{"issue":"11","key":"10.1016\/j.jcyt.2017.09.011_bib0050","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3109\/00207454.2016.1148034","article-title":"Development of stem cell based therapies for Parkinson's disease","volume":"126","author":"Zhu","year":"2016","journal-title":"Int J Neurosci"},{"issue":"8","key":"10.1016\/j.jcyt.2017.09.011_bib0055","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2217\/rme-2016-0102","article-title":"Cell therapies for Parkinson's disease: how far have we come?","volume":"11","author":"Stoker","year":"2016","journal-title":"Regen Med"},{"key":"10.1016\/j.jcyt.2017.09.011_bib0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbi.2015.12.021","article-title":"Xenograft of human umbilical mesenchymal stem cells from Wharton's jelly as a potential therapy for rat pilocarpine-induced epilepsy","volume":"54","author":"Huang","year":"2016","journal-title":"Brain Behav Immun"},{"issue":"6","key":"10.1016\/j.jcyt.2017.09.011_bib0065","doi-asserted-by":"crossref","first-page":"e0128973","DOI":"10.1371\/journal.pone.0128973","article-title":"Safety and efficacy of human Wharton's jelly-derived mesenchymal stem cells therapy for retinal degeneration","volume":"10","author":"Leow","year":"2015","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.jcyt.2017.09.011_bib0070","doi-asserted-by":"crossref","first-page":"11692","DOI":"10.3390\/ijms140611692","article-title":"Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications","volume":"14","author":"Kim","year":"2013","journal-title":"Int J Mol Sci"},{"issue":"19","key":"10.1016\/j.jcyt.2017.09.011_bib0075","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1089\/scd.2015.0062","article-title":"Genetic engineering of mesenchymal stem cells for regenerative medicine","volume":"24","author":"Nowakowski","year":"2015","journal-title":"Stem Cells Dev"},{"issue":"10","key":"10.1016\/j.jcyt.2017.09.011_bib0080","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1007\/s11064-016-1982-1","article-title":"Neuroprotective effect of the LRRK2 kinase inhibitor PF-06447475 in human nerve-like differentiated cells exposed to oxidative stress stimuli: implications for Parkinson's disease","volume":"41","author":"Mendivil-Perez","year":"2016","journal-title":"Neurochem Res"},{"issue":"5","key":"10.1016\/j.jcyt.2017.09.011_bib0085","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jcyt.2017.09.011_bib0090","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10561-013-9364-2","article-title":"Dissimilar characteristics of umbilical cord mesenchymal stem cells from donors of different ages","volume":"14","author":"Huang","year":"2013","journal-title":"Cell Tissue Bank"},{"issue":"8","key":"10.1016\/j.jcyt.2017.09.011_bib0095","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ajmg.b.30375","article-title":"A genetic cluster of early onset Parkinson's disease in a Colombian population","volume":"141B","author":"Pineda-Trujillo","year":"2006","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"5","key":"10.1016\/j.jcyt.2017.09.011_bib0100","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1083\/jcb.200809125","article-title":"Parkin is recruited selectively to impaired mitochondria and promotes their autophagy","volume":"183","author":"Narendra","year":"2008","journal-title":"J Cell Biol"},{"issue":"3","key":"10.1016\/j.jcyt.2017.09.011_bib0105","first-page":"111","article-title":"Optimizing transfection of umbilical cord mesenchymal stem cells utilizing minicircle plasmid\/lipofectamine LTX complex","volume":"1","author":"Daneshvar","year":"2014","journal-title":"J Appl Biotechnol Rep"},{"issue":"2","key":"10.1016\/j.jcyt.2017.09.011_bib0110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3940(00)01733-X","article-title":"A novel Cys212Tyr founder mutation in parkin and allelic heterogeneity of juvenile Parkinsonism in a population from North West Colombia","volume":"298","author":"Pineda-Trujillo","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jcyt.2017.09.011_bib0115","article-title":"Development of a unilaterally-lesioned 6-OHDA mouse model of Parkinson's disease","volume":"60","author":"Thiele","year":"2012","journal-title":"J Vis Exp"},{"key":"10.1016\/j.jcyt.2017.09.011_bib0120","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells, the International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"9","key":"10.1016\/j.jcyt.2017.09.011_bib0125","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1517\/14712598.2015.1051528","article-title":"Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy","volume":"15","author":"Li","year":"2015","journal-title":"Expert Opin Biol Ther"},{"issue":"5","key":"10.1016\/j.jcyt.2017.09.011_bib0130","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.freeradbiomed.2006.12.004","article-title":"Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: involvement of hydrogen peroxide-dependent and -independent action","volume":"42","author":"Saito","year":"2007","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"10.1016\/j.jcyt.2017.09.011_bib0135","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1159\/000430271","article-title":"Allicin protects PC12 cells against 6-OHDA-induced oxidative stress and mitochondrial dysfunction via regulating mitochondrial dynamics","volume":"36","author":"Liu","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jcyt.2017.09.011_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/163913","article-title":"The bad, the good and the ugly about oxidative stress","volume":"2012","author":"Jimenez-Del-Rio","year":"2012","journal-title":"Oxid Med Cellular Long"},{"issue":"1","key":"10.1016\/j.jcyt.2017.09.011_bib0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.14348\/molcells.2016.2349","article-title":"The roles of peroxiredoxin and thioredoxin in hydrogen peroxide sensing and in signal transduction","volume":"39","author":"Netto","year":"2016","journal-title":"Mol Cells"},{"key":"10.1016\/j.jcyt.2017.09.011_bib0150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ceb.2014.09.010","article-title":"ROS-dependent signal transduction","volume":"33","author":"Reczek","year":"2015","journal-title":"Curr Opin Cell Biol"},{"issue":"3","key":"10.1016\/j.jcyt.2017.09.011_bib0155","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.bbrc.2004.03.110","article-title":"Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells","volume":"317","author":"Kinumi","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.jcyt.2017.09.011_bib0160","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.bbrc.2009.10.025","article-title":"DJ-1 binds to mitochondrial complex I and maintains its activity","volume":"390","author":"Hayashi","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.jcyt.2017.09.011_bib0165","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3164\/jcbn.13-108","article-title":"Oxidized DJ-1 as a possible biomarker of Parkinson's disease","volume":"54","author":"Saito","year":"2014","journal-title":"J Clin Biochem Nutr"},{"issue":"9","key":"10.1016\/j.jcyt.2017.09.011_bib0170","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1093\/emboj\/17.9.2596","article-title":"Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1","volume":"17","author":"Saitoh","year":"1998","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.jcyt.2017.09.011_bib0175","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/jcp.10080","article-title":"Activation of apoptosis signal-regulating kinase 1 by the stress-induced activating phosphorylation of pre-formed oligomer","volume":"191","author":"Tobiume","year":"2002","journal-title":"J Cell Physiol"},{"issue":"3","key":"10.1016\/j.jcyt.2017.09.011_bib0180","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/embo-reports\/kve046","article-title":"ASK1 is required for sustained activations of JNK\/p38 MAP kinases and apoptosis","volume":"2","author":"Tobiume","year":"2001","journal-title":"EMBO Rep"},{"issue":"5","key":"10.1016\/j.jcyt.2017.09.011_bib0185","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.3892\/mmr.2014.1981","article-title":"c-Jun transactivates Puma gene expression to promote osteoarthritis","volume":"9","author":"Lu","year":"2014","journal-title":"Mol Med Rep"},{"issue":"4","key":"10.1016\/j.jcyt.2017.09.011_bib0190","doi-asserted-by":"crossref","first-page":"371","DOI":"10.15252\/embj.201593723","article-title":"Doughnuts, daisy chains and crescent moons: the quest for the elusive apoptotic pore","volume":"35","author":"Dewson","year":"2016","journal-title":"EMBO J"},{"key":"10.1016\/j.jcyt.2017.09.011_bib0195","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/onc.2009.45","article-title":"PUMA, a potent killer with or without p53","volume":"27","author":"Yu","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.jcyt.2017.09.011_bib0200","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.freeradbiomed.2013.01.003","article-title":"Oxidative damage to macromolecules in human Parkinson disease and the rotenone model","volume":"62","author":"Sanders","year":"2013","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.jcyt.2017.09.011_bib0205","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12035-013-8483-x","article-title":"The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes","volume":"49","author":"Niranjan","year":"2014","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jcyt.2017.09.011_bib0210","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JPD-160989","article-title":"PINK1, Parkin, and mitochondrial quality control: what can we learn about Parkinson's disease pathobiology?","volume":"7","author":"Truban","year":"2017","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.jcyt.2017.09.011_bib0215","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1326-6-34","article-title":"Oxidation of the cysteine-rich regions of parkin perturbs its E3 ligase activity and contributes to protein aggregation","volume":"6","author":"Meng","year":"2011","journal-title":"Mol Neurodegener"},{"issue":"4","key":"10.1016\/j.jcyt.2017.09.011_bib0220","first-page":"1","article-title":"Parkin, Parkinson disease gene product, directly reduces hydrogen peroxide (mitochondrial oxidant), and forms dimerization reversibly","volume":"5","author":"Kitada","year":"2016","journal-title":"Int J Latest Res Sci Technol"},{"issue":"2","key":"10.1016\/j.jcyt.2017.09.011_bib0225","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.embor.7400074","article-title":"DJ-1 has a role in antioxidative stress to prevent cell death","volume":"5","author":"Taira","year":"2004","journal-title":"EMBO Rep"},{"issue":"5","key":"10.1016\/j.jcyt.2017.09.011_bib0230","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/j.1471-4159.2008.05277.x","article-title":"Parkin protects against tyrosinase-mediated dopamine neurotoxicity by suppressing stress-activated protein kinase pathways","volume":"105","author":"Hasegawa","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.jcyt.2017.09.011_bib0235","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.brainresbull.2016.12.004","article-title":"Parkin and PINK1 functions in oxidative stress and neurodegeneration","volume":"133","author":"Barodia","year":"2017","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.jcyt.2017.09.011_bib0240","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fnagi.2016.00117","article-title":"A Compendium of preparation and application of stem cells in Parkinson's disease: current status and future prospects","volume":"8","author":"Shen","year":"2016","journal-title":"Front Aging Neurosci"},{"issue":"9","key":"10.1016\/j.jcyt.2017.09.011_bib0245","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/ejn.12872","article-title":"Evidence for a common biological pathway linking three Parkinson's disease-causing genes: parkin, PINK1 and DJ-1","volume":"41","author":"van der Merwe","year":"2015","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.jcyt.2017.09.011_bib0250","series-title":"Identification of novel biologically active DJ-1 small molecule modulators with activity in cellular and in vivo models of oxidative stress relevant to Parkinson's disease","author":"Toth","year":"2016"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324917307107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324917307107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:32:05Z","timestamp":1761442325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324917307107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1465324917307107"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2017.09.011","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PARKIN overexpression in human mesenchymal stromal cells from Wharton's jelly suppresses 6-hydroxydopamine\u2013induced apoptosis: Potential therapeutic strategy in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2017.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}